Robenacoxib
Robenacoxib
|
Names |
IUPAC name
{5-Ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]phenyl}acetic acid |
Identifiers |
3D model (Jmol) |
Interactive image |
ChEBI |
CHEBI:76269 |
ChemSpider |
4938295 |
PubChem |
6433107 |
InChI=1S/C16H13F4NO2/c1-2-8-3-4-12(9(5-8)6-13(22)23)21-16-14(19)10(17)7-11(18)15(16)20/h3-5,7,21H,2,6H2,1H3,(H,22,23) Key: ZEXGDYFACFXQPF-UHFFFAOYSA-N InChI=1/C16H13F4NO2/c1-2-8-3-4-12(9(5-8)6-13(22)23)21-16-14(19)10(17)7-11(18)15(16)20/h3-5,7,21H,2,6H2,1H3,(H,22,23) Key: ZEXGDYFACFXQPF-UHFFFAOYAN
|
O=C(O)Cc2c(Nc1c(F)c(F)cc(F)c1F)ccc(c2)CC
|
Properties |
|
C16H13F4NO2 |
Molar mass |
327.28 g·mol−1 |
Pharmacology |
|
QM01AH91 (WHO) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Infobox references |
|
|
Robenacoxib (Onsior) is a non-steroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the relief of pain and inflammation in cats and dogs.[1]
References
|
---|
|
Receptor (ligands) | DP (D2) | |
---|
| EP (E2) | |
- Antagonists: AH-6809
- ONO-8130
- SC-19220
- SC-51089
- SC-51322
|
---|
| |
- Antagonists: AH-6809
- PF-04418948
- TG 4-155
|
---|
| | |
---|
| |
- Antagonists: GW-627368
- L-161982
- ONO-AE3-208
|
---|
| Unsorted | |
---|
|
---|
| FP (F2α) | |
---|
| IP (I2) | |
---|
| TP (TXA2) | |
---|
| Unsorted |
- Arbaprostil
- Ataprost
- Ciprostene
- Clinprost
- Cobiprostone
- Delprostenate
- Deprostil
- Dimoxaprost
- Doxaprost
- Ecraprost
- Eganoprost
- Enisoprost
- Eptaloprost
- Esuberaprost
- Etiproston
- Fenprostalene
- Flunoprost
- Froxiprost
- Lanproston
- Limaprost
- Luprostiol
- Meteneprost
- Mexiprostil
- Naxaprostene
- Nileprost
- Nocloprost
- Ornoprostil
- Oxoprostol
- Penprostene
- Pimilprost
- Piriprost
- Posaraprost
- Prostalene
- Rioprostil
- Rivenprost
- Rosaprostol
- Spiriprostil
- Tiaprost
- Tilsuprost
- Tiprostanide
- Trimoprostil
- Viprostol
|
---|
|
---|
|
Enzyme (inhibitors) | |
---|
|
Others | |
---|
|
See also: Leukotrienergics |